FDA-Drug2026-09-02Class IICHEMICAL

Accord Healthcare levothyroxine 100 mcg tablets recalled for subpotency

LABEL MIX UPNationwide distributionDrugs

What this means

Accord Healthcare is recalling certain batches of levothyroxine sodium 100 mcg tablets because they may contain less active ingredient than labeled. This affects patients who rely on consistent thyroid hormone dosing. The affected lots were distributed nationwide.

  • Check your levothyroxine bottle for the lot number and expiration date against the recall list.
  • Contact your pharmacy or doctor if you have an affected lot — do not stop taking your medication without medical guidance.
  • Your doctor may ask you to get a thyroid function test to confirm your dose remains effective.
Get recalls like this in a free plain-English brief every Sunday.Get alerts ↓
The agency's original wording
Hazard

Subpotent Drug

Intended for
Adults
Illnesses reported
None reported
Sold states
Nationwide within the United States
Affected count
N/A
Manufactured in
8041 Arco Corporate Dr Ste 200, N/A, Raleigh, NC, United States
Products
Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg), packaged in a) 90-count bottles (NDC 16729-451-15) and b) 1000-count bottles, (NDC 16729-451-17), Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India.

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0779-2026

More Accord Healthcare recalls

Want us to check the next one for you?

We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Free · One email a week · Unsubscribe anytime
By signing up you agree to our Terms and Privacy Policy.